Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR‐HF trial

In heart failure (HF), implantable haemodynamic monitoring devices have been shown to optimize therapy, anticipating clinical decompensation and preventing hospitalization. Direct left‐sided haemodynamic sensors offer theoretical benefits beyond pulmonary artery pressure monitoring systems. We evaluated the safety, usability, and performance of a novel left atrial pressure (LAP) monitoring system in HF patients.

[1]  F. Burzotta,et al.  A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road , 2022, Frontiers in Cardiovascular Medicine.

[2]  M. Link,et al.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Circulation.

[3]  F. Crea,et al.  The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients with Heart Failure: Remote Left Atrial Pressure Monitoring. , 2022, Journal of cardiac failure.

[4]  Akshay S. Desai,et al.  Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial , 2021, The Lancet.

[5]  M. Murero,et al.  Implantation of an Innovative Intracardiac Microcomputer System for Web-Based Real-Time Monitoring of Heart Failure: Usability and Patients’ Attitudes , 2021, JMIR cardio.

[6]  H. Ince,et al.  Intra-cardiac microcomputer allows for innovative telemedicine in chronic heart failure during coronavirus disease-2019 pandemic: a case report , 2020, European heart journal. Case reports.

[7]  R. Kornowski,et al.  A rise in left atrial pressure detected by the V‐LAP™ system for patients with heart failure during the coronavirus disease 2019 pandemic , 2020, ESC heart failure.

[8]  J. Brachmann,et al.  Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS‐HF) , 2020, European journal of heart failure.

[9]  C. Trani,et al.  Experience of remote cardiac care during the COVID‐19 pandemic: the V‐LAP™ device in advanced heart failure , 2020, European journal of heart failure.

[10]  W. Abraham,et al.  A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience , 2019, Journal of Cardiovascular Translational Research.

[11]  L. Stevenson,et al.  Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. , 2017, Journal of the American College of Cardiology.

[12]  W. Abraham,et al.  Implantable Hemodynamic Monitoring for Heart Failure Patients. , 2017, Journal of the American College of Cardiology.

[13]  Jagmeet P. Singh,et al.  Hemodynamic Monitoring in Advanced Heart Failure: Results from the LAPTOP-HF Trial , 2016 .

[14]  Gianluigi Savarese,et al.  Global Public Health Burden of Heart Failure. , 2016, Cardiac failure review.

[15]  Ellis Meng,et al.  Chronically Implanted Pressure Sensors: Challenges and State of the Field , 2014, Sensors.

[16]  C. Ayers,et al.  Relationship of Right- to Left-Sided Ventricular Filling Pressures in Advanced Heart Failure: Insights From the ESCAPE Trial , 2013, Circulation. Heart failure.

[17]  M. Drazner,et al.  Mismatch of right- and left-sided filling pressures in chronic heart failure. , 2011, Journal of cardiac failure.

[18]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[19]  William T. Abraham,et al.  Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance , 2010, Journal of cardiovascular translational research.

[20]  P. Austin,et al.  "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure. , 2009, The American journal of medicine.

[21]  M. Zile,et al.  Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures , 2008, Circulation.

[22]  William T. Abraham,et al.  Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device , 2007, Circulation.

[23]  L. Køber,et al.  Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes , 2007, Circulation.

[24]  Saibal Kar,et al.  Images in cardiovascular medicine. Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device. , 2006, Circulation.

[25]  L. Rydén,et al.  Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. , 2003, Journal of the American College of Cardiology.

[26]  Philip Adamson,et al.  Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. , 2002, Journal of cardiac failure.

[27]  W. Stewart,et al.  Effects of mitral regurgitation on pulmonary venous flow and left atrial pressure: an intraoperative transesophageal echocardiographic study. , 1992, Journal of the American College of Cardiology.

[28]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.